The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Occupational exposures to metals as risk factors for Parkinson's disease
Abstract
In a population-based case-control study, we investigated the potential role of occupational exposure to iron, copper, manganese, mercury, zinc, and lead as risk factors for Parkinson's disease (PD). Concurrently recruited, nondemented patients (n = 144) with idiopathic PD and controls (n = 464) consisting of men and women > or =50 years of age, frequency-matched for age (within 5 years), race, and sex were enrolled. All had primary medical care at Henry Ford Health System in urban/suburban metropolitan Detroit. Subjects were given an extensive risk-factor questionnaire detailing actual worksite conditions of all jobs held for more than 6 months from age 18 onward. An industrial hygienist, blinded to the case-control status of subjects, rated occupational exposure to each of the metals of interest. When adjusted for sex, race, age, and smoking status, we found in those with more than 20 years' exposure a significantly increased association with PD for copper (OR = 2.49, 95% CI = 1.06, 5.89) and manganese (OR = 10.61, 95% CI = 1.06, 105.83). For more than 20 years' exposure to combinations of lead-copper (OR = 5.24, 95% CI = 1.59, 17.21), lead-iron (OR = 2.83, 95% CI = 1.07, 7.50), and iron-copper (OR = 3.69, 95% CI = 1.40, 9.71), there was a greater association with PD than with any of these metals alone. These findings suggest that chronic exposure to these metals is associated with PD, and that they may act alone or together over time to help produce the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,725
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Anthony, J. C., LeResche, L., Niaz, U., Von Korff, M. R., & Folstein, M. F. (1982) · Psychological Medicine · doi:10.1017/s0033291700046730 · Cited by 1,110
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
Gerlach, M., Ben‐Shachar, D., Riederer, P., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 703
Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
Sofic, E., Paulus, W., Jellinger, K., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 524
The properties of streptavidin, a biotin-binding protein produced by Streptomycetes
Chaiet, L., & Wolf, F. J. (1964) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(64)90150-x · Cited by 513
Chronic manganese poisoning: Clinical picture and manganese turnover
Mena, I., Marin, O., Fuenzalida, S., & Cotzias, G. C. (1967) · Neurology · doi:10.1212/wnl.17.2.128 · Cited by 441
Neurosurgical horizons in Parkinson's disease
Goetz, C. G., De Long, M. R., Penn, R. D., & Bakay, R. A. E. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.1 · Cited by 405
Megadose corticosteroids in multiple sclerosis
Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G., McFarland, H., Johnson, K., Reingold, S., & Whitaker, J. (1994) · Neurology · doi:10.1212/wnl.44.1.1 · Cited by 386
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Epidemiology of parkinsonism: Incidence, classification, and mortality
Rajput, A. H., Offord, K. P., Beard, C. M., & Kurland, L. T. (1984) · Annals of Neurology · doi:10.1002/ana.410160303 · Cited by 340
Worldwide Occurrence of Parkinson's Disease: An Updated Review
Zhang, Z.-X., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 329
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
GIBB, W. R. G., & LEES, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 319
Chretien, S., Dubart, A., Beaupain, D., Raich, N., Grandchamp, B., Rosa, J., Goossens, M., & Romeo, P. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.6 · Cited by 301
Parkinson's disease: A case‐control study of occupational and environmental risk factors
Hertzman, C., Wiens, M., Bowering, D., Snow, B., & Calne, D. (1990) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700170307 · Cited by 290
Parkinson's disease: A test of the multifactorial etiologic hypothesis
Semchuk, K. M., Love, E. J., & Lee, R. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1173 · Cited by 275
Parkinson's disease in a Scottish city.
Mutch, W. J., Dingwall-Fordyce, I., Downie, A. W., Paterson, J. G., & Roy, S. K. (1986) · BMJ · doi:10.1136/bmj.292.6519.534 · Cited by 251
Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi
Schoenberg, B. S., Anderson, D. W., & Haerer, A. F. (1985) · Neurology · doi:10.1212/wnl.35.6.841 · Cited by 247
The natural history of lumbosacral plexopathy in cancer
Jaeckle, K. A., Young, D. F., & Foley, K. M. (1985) · Neurology · doi:10.1212/wnl.35.1.8 · Cited by 242
Manganese poisoning and the attack of trivalent manganese upon catecholamines
Archibald, F. S., & Tyree, C. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90621-7 · Cited by 232
Li, S.-C., Schoenberg, B. S., Wang, C.-C., Cheng, X.-M., Rui, D.-Y., Bolis, C. L., & Schoenberg, D. G. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060070045013 · Cited by 217
A new look and feel: Message from the Editor-in-Chief
Daroff, R. B. (1996) · Neurology · doi:10.1212/wnl.46.1.1 · Cited by 213
Duchenne muscular dystrophy: High frequency of deletions
Bartlett, R. J., Pericak-Vance, M. A., Koh, J., Yamaoka, L. H., Chen, J. C., Hung, W. Y., Speer, M. C., Wapenaar, M. C., B. Van Ommen, G. J., Bakker, E., et al. (1988) · Neurology · doi:10.1212/wnl.38.1.1 · Cited by 196
Progression after chronic manganese exposure
Huang, C.-C., Lu, C.-S., Chu, N.-S., Hochberg, F., Lilienfeld, D., Olanow, W., & Calne, D. B. (1993) · Neurology · doi:10.1212/wnl.43.8.1479 · Cited by 194
Parkinson's disease and its comorbid disorders: An analysis of Michigan mortality data, 1970 to 1990
Gorell, J. M., Johnson, C. C., & Rybicki, B. A. (1994) · Neurology · doi:10.1212/wnl.44.10.1865 · Cited by 175
Self-citationGoldstein, S., & Czapski, G. (1986) · Journal of Free Radicals in Biology & Medicine · doi:10.1016/0748-5514(86)90117-0 · Cited by 173
Environmental factors and Parkinson's disease: A case‐control study in China
Tanner, C. M., Chen, B., Wang, W., Peng, M., Liu, Z., Liang, X., Kao, L. C., Gilley, D. W., Goetz, C. G., & Schoenberg, B. S. (1989) · Neurology · doi:10.1212/wnl.39.5.660 · Cited by 170
Parkinson's disease mortality and the industrial use of heavy metals in Michigan
Rybicki, B. A., Johnson, C. C., Uman, J., & Gorell, J. M. (1993) · Movement Disorders · doi:10.1002/mds.870080116 · Cited by 163
Self-citationStudies on the natural history of multiple sclerosis
Beebe, G. W., Kurtzke, J. F., Kurland, L. T., Auth, T. L., & Nagler, B. (1967) · Neurology · doi:10.1212/wnl.17.1.1 · Cited by 159
Prevalence of Parkinson's Disease in the Parsi Community of Bombay, India
Bharucha, N. E., Bharucha, E. P., Bharucha, A. E., Bhise, A. V., & Schoenberg, B. S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520360039008 · Cited by 137
EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASE: III. A COMMUNITY-BASED SURVEY
Kessler, I. I. (1972) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121455 · Cited by 137
Cohler, B. J., ROBBINS, D. M., Hartman, C. R., Shader, R. I., Grunebaum, H. U., Gallant, D. H., & Weiss, J. L. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90017-5 · Cited by 132
The Geographic Distribution of Multiple Sclerosis: A Review
Ebers, G. C., & Sadovnick, A. D. (1993) · Neuroepidemiology · doi:10.1159/000110293 · Cited by 126
Facteurs environnementaux dans l'étiologie de la maladie de Parkinson
Zayed, J., Ducic, S., Campanella, G., Panisset, J.-C., André, P., Masson, H., & Roy, M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030584 · Cited by 124
Ngim, C.-H., & Devathasan, G. (1989) · Neuroepidemiology · doi:10.1159/000110175 · Cited by 109
A CLINICAL SURVEY OF PARKINSONISM IN ICELAND
Guðmundsson, K. R. (1967) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1967.tb07439.x · Cited by 109
Gallo, V., Giovannini, C., Suergiu, R., & Levi, G. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10890.x · Cited by 105
The risk of Parkinson disease in Mediterranean people
Rosati, G., Granieri, E., Pinna, L. A., Aiello, I., Tola, R., Bastiani, P. D., Pirisi, A., & Devoto, M. (1980) · Neurology · doi:10.1212/wnl.30.3.250 · Cited by 95
The natural history of human T lymphotropic virus-III infection: the cause of AIDS.
Melbye, M. (1986) · BMJ · doi:10.1136/bmj.292.6512.5 · Cited by 91
Low-dose clozapine improves dyskinesias in Parkinson's disease
Durif, F., Vidailhet, M., Assal, F., Roche, C., Bonnet, A. M., & Agid, Y. (1997) · Neurology · doi:10.1212/wnl.48.3.658 · Cited by 89
Enhancement of the chromosome-damaging action of ascorbate by transition metals.
STICH, H. F., Wei, L., & Whiting, R. F. (1979) · PubMed · Cited by 87
Parkinsonism death rates by race, sex, and geography
Kurtzke, J. F., & Goldberg, I. D. (1988) · Neurology · doi:10.1212/wnl.38.10.1558 · Cited by 86
Mitochondrial DNA alterations as a source of human disorders
Tritschler, H., & Medori, R. (1993) · Neurology · doi:10.1212/wnl.43.2.280 · Cited by 85
Parkinson's Disease in Ferrara, Italy, 1967 Through 1987
Granieri, E., Carreras, M., Casetta, I., Govoni, V., Tola, M. R., Paolino, E., Monetti, V. C., & Bastiani, P. D. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200096026 · Cited by 82
Sutcliffe, R. L. G., Prior, R., Mawby, B., & McQuillan, W. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1985.tb00886.x · Cited by 77
Incidence and Risk Factors of Parkinson's Disease in The Netherlands
Albert Hofman, D., Collette, H. J. A., & Bartelds, A. I. M. (1989) · Neuroepidemiology · doi:10.1159/000110197 · Cited by 76
Genomic damage and its repair in young and aging brain
Rao, K. S. (1993) · Molecular Neurobiology · doi:10.1007/bf02780607 · Cited by 74
Jiménez‐Jiménez, F. J., Mateo, D., & Giménez-Roldán, S. (1992) · Movement Disorders · doi:10.1002/mds.870070209 · Cited by 72
Oxidative stress and mitochondrial dysfunction in neurodegeneration.
Tritschler, H., Packer, L., & Medori, R. (1994) · PubMed · Cited by 71
A pilot study of occupational and environmental risk factors for Parkinson's disease.
Wechsler, L., Checkoway, H., Franklin, G. M., & Costa, L. G. (1991) · PubMed · Cited by 70
A Case-Control Study on the Environmental Risk Factors of Parkinson's Disease in Tianjin, China
Wang, W., Fang, X., Cheng, X.-M., Jiang, D., & Lin, Z.-J. (1993) · Neuroepidemiology · doi:10.1159/000110319 · Cited by 70
Two Decades of Increasing Mortality From Parkinson's Disease Among the US Elderly
Lilienfeld, D. E., Chan, E., Ehland, J., Godbold, J., Landrigan, P. J., Marsh, G. M., & Perl, D. P. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530070019005 · Cited by 65
The changing patterns of death rates in parkinsonism
Kurtzke, J. F., & Murphy, F. M. (1990) · Neurology · doi:10.1212/wnl.40.1.42 · Cited by 62
Multiple Sclerosis: Changing Times
Kurtzke, J. F. (1991) · Neuroepidemiology · doi:10.1159/000110240 · Cited by 62
Montine, T. J., FARRIS, D. B., & Graham, D. G. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199505000-00004 · Cited by 57
Ohlson, C., & Hogstedt, C. (1981) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.2549 · Cited by 57
A Screening and Alerting Questionnaire for Parkinsonism
Mutch, W. J., Smith, W., & Scott, R. F. (1991) · Neuroepidemiology · doi:10.1159/000110261 · Cited by 51
Rybicki, B. A., Johnson, C. C., & Gorell, J. M. (1995) · Neuroepidemiology · doi:10.1159/000109781 · Cited by 51
Self-citationRelationship of aging to Parkinson's disease.
Koller, W. C., O'Hara, R., Weiner, W. J., Lang, A. E., Nutt, J. G., Agid, Y., Bonnet, A. M., & Jankovic, J. J. (1987) · PubMed · Cited by 48
Mitochondrial DNA damage by anticancer agents
Singh, G., Sharkey, S. M., & Moorehead, R. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90033-v · Cited by 44
Somatic mutations in the brain: relationship to aging?
Evans, D. A. P., Peter, J., Burbach, H., et al. (1995) · Mutation Research/DNAging · doi:10.1016/0921-8734(95)00022-x · Cited by 44
Stengel, B., Pisani, P., Limasset, J. C., Bouyer, J., Berrino, F., & Hémon, D. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.supplement_2.s72 · Cited by 43
Stücker, I., Bouyer, J., MANDEREAU, L., & Hémon, D. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.supplement_2.s106 · Cited by 35
Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans
Paddison, R. M., & GRIFFITH, R. P. (1974) · Neurology · doi:10.1212/wnl.24.7.688 · Cited by 31
Epidemiological Survey of Multiple Sclerosis in the Provinces of Reggio Emilia and Modena, Italy
Guidetti, D., Cavalletti, S., Merelli, E., Zanoni, P., Simonazzi, P., Sola, P., & Solimé, F. (2007) · Neuroepidemiology · doi:10.1159/000109772 · Cited by 31
Youdim, M. B. H., & Riederer, P. F. (1993) · Movement Disorders · doi:10.1002/mds.870080504 · Cited by 27
Itoh, H., Shioda, T., Matsura, T., Koyama, S., Nakanishi, T., Kajiyama, G., & Kawasaki, T. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1367 · Cited by 23
Rossman, T. G. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-79162-8_17 · Cited by 20
Role of Active Oxygen Species in Metal-Induced DNA Damage
Kawanishi, S. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-79162-8_16 · Cited by 16
Clues from epidemiology of Parkinson's disease.
Rj, M., & Rinne, U. K. (1987) · PubMed · Cited by 14
Generation of nitric oxide inhibits formation of superoxide in macrophages during activation.
Cd, J., Jy, L., Lee, B., Choi, B., Jy, U., Hj, K., Ky, J., Hm, K., & Ht, C. (1994) · PubMed · Cited by 7
Cited by
The Toxicology of Mercury and Its Chemical Compounds
Clarkson, T. W., & Magos, L. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600845619 · Cited by 2,371
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Metadata
- Authors
- Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., & Richardson, R. J.
- Venue
- Neurology
- Published
- 1997-03
- Volume
- 48
- Issue
- 3
- Pages
- 650-658
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2069702585
- Cited by
- 476
- References
- 75
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.